Short-Term Debt to Equity Ratio: Assertio (ASRT)
The market valuation dynamics for Assertio Holdings, Inc. (ASRT) on the GURU.Markets platform, where the indicator stands at 0.00, characterize Assertio Holdings, Inc. (ASRT) as an authoritative manufacturer of chronic pain management treatments. Physicians value the brand for the effectiveness of its prescription solutions. The company adheres to basic environmental standards by focusing on office digitalization, while its success relies on patent extensions and the acquisition of new drug brands.
Analytical breakdowns for Assertio Holdings, Inc.
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Capital Assertio Holdings, Inc.|ASRT - Long-Term Debt to Capital|Short-Term Debt to Equity Assertio Holdings, Inc.|ASRT - Company Total Debt Obligations|Debt to Book Capitalization Ratio Assertio Holdings|ASRT - Long-Term Debt Volume|Company Short-Term Debts Assertio|Quick Liquidity assertiotx.com
- company profitability and valuation multiples indicators:
Basic company analysis:ASRT Assertio
Operational liquidity is critical for Assertio Holdings, Inc. (ASRT), as its revenues depend on the sale of prescription drugs and licensing royalties. By analyzing changes in the share of short-term liabilities within the capital structure, an investor assesses the ratio of current loans to equity, which helps determine the risk of default or the potential for asset dilution amid shifts in the company's market value and the availability of debt financing.
Main competitors
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Short-Term Debt to Capital|Short-Term Debt to Capital denalitherapeutics.com|Short-Term Debt to Equity Harmony Biosciences Holdings, Inc. (HRMY)|Short-Term Debt to Capital Coefficient Biohaven Ltd|Short-Term Debt to Equity Amylyx AMLX|Short-Term Debt to Capital Coefficient Trevi Corp (TRVI)|Praxis Precision Medicines - Short-Term Debt to Capital|Current Liabilities to Capital anavex.com|CeriBell (CBLL) - Short-Term Debt to Equity|Prothena Biosciences - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ALEC|ANNX (Annexon Biosciences Inc.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital OMER|Short-Term Debt to Capital Coefficient neurogene.com|Short-Term Debt to Equity AC Immune SA ACIU|Voyager Therapeutics Inc (VYGR) - Current Liabilities to Capital|NMRA: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital SCLX (Scilex Holding Company, Inc.)|TVGN: Short-Term Debt to Capital|Alpha Cognition Inc. - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Cognition Therapeutics, Inc.|Current Liabilities to Capital Inhibikase Therapeutics Inc IKT|Short-Term Debt to Equity Cassava (SAVA)|Short-Term Debt to Equity COYA (coyatherapeutics.com)|Short-Term Debt to Capital VTGN (Vistagen)|OVID: Short-Term Debt to Capital Ratio|Acumen Pharmaceuticals, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient CervoMed, Inc. CRVO|alteritytherapeutics.com (ATHE) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio CLNN|PEPG (PepGen Inc) - Short-Term Debt to Capital|JUNS - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Relmada Therapeutics, Inc. (RLMD)|Short-Term Debt to Capital Coefficient Annovis Bio Inc|Grace Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AIFF|ANEW Medical, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient NeuroSense Therapeutics NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio MTVA|NRXS (NeurAxis, Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Helius Medical Technologies Inc. (HSDT)|Short-Term Debt to Equity Ratio PASG (Passage Bio, Inc.)|Short-Term Debt to Capital Coefficient bionomics.com.au|Short-Term Debt to Capital NERV (Minerva Neurosciences, Inc.)|Short-Term Debt to Capital Athira Pharma Inc ATHA|ADXN - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Alzamend Neuro, Inc. ALZN|cyclerion.com (CYCN) - Short-Term Debt to Equity|Protagenic Therapeutics, Inc. - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio KTTA|CRGT (Cortigent Medical) - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity Avenue Therapeutics, Inc (ATXI)|BrainStorm Cell Therapeutics Inc. - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital CARA (Cara Therapeutics, Inc.)|chromocell.com (CHRO) - Current Liabilities to Capital|ELYM: Short-Term Debt to Equity Ratio|ITCI - Short-Term Debt to Capital|Longboard Pharma (LBPH) - Short-Term Debt to Equity|Marinus Pharma - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity NKGen Biotech, Inc.|Current Liabilities to Capital neurobopharma.com NRBO|Short-Term Debt to Capital SAGE|Short-Term Debt to Capital Synaptogenix Inc. (SNPX)|Short-Term Debt to Equity Trevena, Inc TRVN|Short-Term Debt to Capital Coefficient Vigil Neuroscience Inc. (VIGL)|WENA - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient cerevel.com CERE